LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Edwards Lifesciences Corp

Fermé

SecteurSoins de santé

77.57 -0.12

Résumé

Variation du prix de l'action

24h

Actuel

Min

76.83

Max

77.73

Chiffres clés

By Trading Economics

Revenu

-28M

358M

Ventes

27M

1.4B

P/E

Moyenne du Secteur

32.273

51.198

BPA

0.64

Marge bénéficiaire

25.342

Employés

15,800

EBITDA

-50M

434M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+5.82% upside

Dividendes

By Dow Jones

Prochains Résultats

23 juil. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.1B

46B

Ouverture précédente

77.69

Clôture précédente

77.57

Sentiment de l'Actualité

By Acuity

39%

61%

126 / 380 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bearish Evidence

Edwards Lifesciences Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 juil. 2024, 13:57 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences to Buy Innovalve for $300 Million

25 oct. 2024, 09:10 UTC

Résultats

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

25 oct. 2024, 08:35 UTC

Résultats

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

3 sept. 2024, 20:38 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3 sept. 2024, 20:37 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3 sept. 2024, 20:36 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

25 juil. 2024, 09:02 UTC

Résultats
Actions en Tendance

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

25 juil. 2024, 08:40 UTC

Actualités

These Stocks Are Moving the Most Today: Ford, Tesla, Alphabet, Nvidia, Super Micro, IBM, ServiceNow, Chipotle, and More -- Barrons.com

24 juil. 2024, 20:17 UTC

Résultats

Edwards Lifesciences: Expects 2024 Edwards Sales Growth of 8% to 10% >EW

24 juil. 2024, 20:15 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

24 juil. 2024, 20:15 UTC

Résultats

Edwards Lifesciences 2Q Sales $1.39B >EW

24 juil. 2024, 20:15 UTC

Résultats

Edwards Lifesciences 2Q Net $366.3M >EW

24 juil. 2024, 20:15 UTC

Résultats

Edwards Lifesciences 2Q Adj EPS 70c >EW

24 juil. 2024, 20:15 UTC

Résultats

Edwards Lifesciences 2Q EPS 61c >EW

15 juil. 2024, 13:42 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences to Buy Innovalve for $300M

15 juil. 2024, 13:01 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences: SAPIEN M3 Remains on Track to Become First Approved Transfemoral TMVR System in Europe by End of 2025 >EW

15 juil. 2024, 13:01 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences: Acquisition Enhances TMVR Technologies to Address Large Unmet Structural Heart Patient Needs >EW

15 juil. 2024, 13:00 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences to Acquire Innovalve Bio Medical Ltd., Early-Stage Transcatheter Mitral Valve Replacement Co >EW

15 juil. 2024, 13:00 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences To Acquire Innovalve >EW

Comparaison

Variation de prix

Edwards Lifesciences Corp prévision

Objectif de Prix

By TipRanks

5.82% hausse

Prévisions sur 12 Mois

Moyen 82.3 USD  5.82%

Haut 95 USD

Bas 75 USD

Basé sur 15 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

15 ratings

7

Achat

8

Maintien

0

Vente

Score Technique

By Trading Central

74.52 / 75.54Support & Résistance

Court Terme

Weak Bearish Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Strong Bullish Evidence

Sentiment

By Acuity

126 / 380Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.